CML-CP: SNPs in MDR-ABC transporters influence achievement of MR in nilotinib-treated patientsJune 9, 2021CML
Suppression of random mutations may reduce blast crisis risk in TKI-treated CML patientsJune 9, 2021CML
Hematology NewsPediatric cancer survivors at risk for opioid misuseMay 5, 2021ALLPatient & Survivor CareOpioid Resource CenterPediatricsCNS/Brain CancerLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
CML-CP: Investigating bone marrow LSC before TKI discontinuation could help maintain stable TFRMay 5, 2021CML
